iSeed

iSeed Ventures is a San Francisco-based early-stage venture capital firm that invests in innovative startups across diverse sectors, focusing on enterprises leveraging AI, digital health, and enterprise software. The firm manages over $200 million in assets under management (AUM) and has made more than 37 investments, with an average historical check size of $1.5 million to $2 million. Its portfolio primarily targets seed-stage companies in North America, with digital health representing approximately 40% of its investments. Notable portfolio companies include Final Round AI, Cricket Health, Canvas Medical, and 9am.health; the firm also saw 1DocWay acquired by United Healthcare in 2024. iSeed Ventures was founded in 2014 by Adam Lin. Its business model centers on venture capital firm managing over $200M in assets under management , funded through limited partners.

iSeed operates as a micro-fund, providing early-stage capital to technology companies in the Indian market. The firm identifies and cultivates innovative startups, offering financial investment, strategic guidance, and access to a global network of seasoned entrepreneurs. Its model emphasizes active support for portfolio companies through initial growth phases, fostering robust development.

Established in 2020, iSeed was founded by Utsav Somani, known for establishing AngelList's presence in India. Somani conceived India's first micro-fund, uniquely supported by successful global founders and investors. This insight aimed to inject entrepreneurial expertise and strategic capital into promising Indian ventures.

The firm’s investments primarily target early and growth-stage Indian technology startups. iSeed’s overarching vision is to empower future Indian entrepreneurs, recognizing the immense potential within the country’s burgeoning startup ecosystem. By linking local innovators with international insights and funding, iSeed endeavors to accelerate their development and cultivate a globally competitive landscape.